Evidence map›Paper›PMID 20932824›Full record

ArticleClinica chimica acta; international journal of clinical chemistry2011

A de novo mutation in NKX2.5 associated with atrial septal defects, ventricular noncompaction, syncope and sudden death.

Ping Ouyang, Elizabeth Saarel, Ying Bai, Chunyan Luo, Qiulun Lv, Yan Xu, Fan Wang, Chun Fan, Adel Younoszai, Qiuyun Chen and 2 more

Abstract read
In one paragraph

Article in Clinica chimica acta; international journal of clinical chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. A Novel Missense Heterozygous Mutation inJournal of pediatric genetics · 2024
    Article
  6. Review
  7. A NovelJournal of clinical medicine · 2022
    Article
  8. Article
  9. Article
  10. The role of NKX2-5 gene polymorphisms in congenital heart disease (CHD): a systematic review and meta-analysis.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2021
    Article
  11. Article
  12. Review
  13. Genetics of inherited cardiomyopathies in Africa.Cardiovascular diagnosis and therapy · 2020
    Review
  14. Article
  15. Extracellular Matrix Disparities in anFrontiers in cardiovascular medicine · 2020
    Article
  16. A comprehensive in silico analysis, distribution and frequency of humanJournal of cardiovascular and thoracic research · 2019
    Article
  17. Expanding the electrical phenotype ofHeartRhythm case reports · 2018
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ping OuyangKey Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, and Center for Human Genome Research, Cardio-X Institute, Huazhong University of Science and Technology, Wuhan, PR China.
Elizabeth Saarel
Ying Bai
Chunyan Luo
Qiulun Lv
Yan Xu
Fan Wang
Chun Fan
Adel Younoszai
Qiuyun Chen
Xin Tu
Qing K Wang

Funding

Novel Role of a Nucleoporin Gene in Atrial Fibrillation, the Most Common CardiacR01HL094498 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI WANG, QING KENNETH · 2010 to 2013
$1.5M
NHLBI NIH HHS R01 HL094498
6 · The paper itself

Abstract

backgroundMutations in transcription factor NKX2.5 cause congenital heart disease (CHD). We identified a CHD family with atrial septal defects (ASDs), atrioventricular block, ventricular noncompaction, syncope and sudden death. Our objective is to identify the disease-causing mutation in the CHD family.

methodsDirect DNA sequence analysis was used to identify the CHD mutation. The functional effects of the mutation were characterized by a luciferase reporter assay and immunostaining.

resultsA novel, de novo 2-bp insertion (c.512insGC) was identified in exon 2 of NKX2.5. Mutation c.512insGC co-segregates with CHD in the family, and is not present in 200 controls. Functional studies indicate that the c.512insGC mutation impedes nuclear localization of NKX2.5 and causes a total loss of transactivation activity of NKX2.5. Furthermore, no NKX2.5 mutation was identified in 125 sporadic Chinese CHD patients.

conclusions(1) NKX2.5 mutation c.512insGC is associated with ASDs, syncope and sudden death. It is the second de novo mutation identified in NKX2.5. (2) NKX2.5 mutations are rare in sporadic CHD patients. (3) This study for the first time identifies association between a NKX2.5 mutation and ventricular noncompaction. Our results significantly expand the phenotypic spectrum of NKX2.5 mutations.

Indexed as

Death, SuddenMutationAdultBase SequenceDNA Mutational AnalysisFemaleHeart Septal Defects, AtrialHeLa CellsHomeobox Protein Nkx-2.5Homeodomain ProteinsHumansIsolated Noncompaction of the Ventricular MyocardiumMaleModels, MolecularNucleic Acid ConformationSyncopeHomeobox Protein Nkx-2.5Homeodomain ProteinsNKX2-5 protein, humanTranscription Factors

Identifiers

PMID20932824
PMCPMC2998397

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.